• Havva Kocayiğit, Kezban Özmen Süner, Yakup Tomak, Gürkan Demir, İbrahim Kocayiğit, Selçuk Yaylacı, Yusuf Aydemir, Mehmet Köroğlu, Oğuz Karabay, Mehmet Halil Öztürk, and Ali Fuat Erdem.
• Department of Anaesthesiology and Reanimation, Sakarya University Education and Research Hospital, Sakarya, Turkey
• Turk J Med Sci. 2021 Apr 30; 51 (2): 440447440-447.

Background/AimSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Turkey on March 10, 2020 and the number of the patients are increasing day by day. Coronavirus disease 2019 (Covid-19) has high mortality rates in intensive care units (ICUs). We aimed to describe the demographic characteristics, comorbidities, treatment protocols, and clinical outcomes among the critically ill patients admitted to the ICU of our hospital.Materials And MethodsThis cohort study included 103 consecutive patients who had laboratory confirmed Covid-19 and admitted to ICU of Sakarya University Training and Research Hospital between March 19 and April 13, 2020. The final date of the follow-up was April 18.ResultsThe mean age of the patients was 69.6 ± 14.1 years. Most of the patients had increased CRP (99%), serum ferritin (73.8%), d-dimer (82.5%), and hs-troponin levels (38.8%). 34 patients (33%) had lymphocytopenia, 24 patients (23.3%) had thrombocytopenia. 63 patients (61.2%) developed acute respiratory distress syndrome (ARDS), 31 patients (30.1%) had acute kidney injury, and 52 patients (50.5%) had multiple organ dysfunction syndrome (MODS) during follow-up. Sixty-two patients (60.2%) received mechanical ventilation. As of April 18, of the 103 patients, 52 (50.5%) had died, 30 (29.1%) had been discharged from the ICU, 21 (20.4%) were still in the ICU.ConclusionsCovid-19 has high mortality rates in ICU. Patients with elevated procalcitonin, hs-troponin, d-dimer, and CRP levels and lower platelet count at admission have higher mortality.This work is licensed under a Creative Commons Attribution 4.0 International License.

56 keywords...

hide…